Biópsia aspirativa transtorácica por agulha fina guiada por TC de lesões pulmonares: resultados e complicações

Lima, Cristiano Dias de; Nunes, Rodolfo Acatauassú; Saito, Eduardo Haruo; Higa, Cláudio; Cardona, Zanier José Fernando; Santos, Denise Barbosa

doi:10.1590/s1806-37132011000200011

Cited by 14 publications

(3 citation statements)

References 19 publications

(41 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 34 Some groups have also developed expertise in CT-guided transthoracic fine-needle aspiration, showing high diagnostic yield, accuracy, and safety. 35 After 2010, endobronchial ultrasound was introduced in a few large institutions, and the initial experience with 50 cases has been reported. 36 , 37 In most cases, endobronchial ultrasound was recommended for diagnostic purposes (76%), yielding adequate specimens in 74% of the cases.…”

Section: Diagnostic Proceduresmentioning

confidence: 99%

Lung cancer in Brazil

2018

View full text Add to dashboard Cite

Lung cancer is one of the most incident types of cancer and a leading cause of cancer mortality in Brazil. We reviewed the current status of lung cancer by searching relevant data on prevention, diagnosis, and treatment in the country. This review highlights several issues that need to be addressed, including smoking control, patient lack of awareness, late diagnosis, and disparities in the access to cancer health care facilities in Brazil. We propose strategies to help overcome these limitations and challenge health care providers, as well as the society and governmental representatives, to work together and to take a step forward in fighting lung cancer.

show abstract

Section: Diagnostic Proceduresmentioning

confidence: 99%

Lung cancer in Brazil

2018

View full text Add to dashboard Cite

show abstract

“…With regard to other pathology findings, the malignancy rate was the highest for specific malignancy (99.8%, 95% CI, 99.7–99.9%; I 2 = 0.00; 11,884 biopsies in 114 studies) 3,4,6–9,11–23,25–68,70,72–76,78,79,81–86,88,90–93,96,99–101,103–105,108,113–115,118–120,124,126–130,132,134,138–147 , followed by atypical cells (91.1%, 95% CI, 87.8–94.5%; I 2 = 0.23; 312 biopsies in 41 studies) 4,9,13,14,17–20,26,27,29,30,34,37,41,42,46,47,53,64,66,70,74–76,79,85,86,89–91,98,101,104,108,115,120,126,129,144,147 , AAH (88.9%, 95% CI, 76.7–100.0%; I 2 = 0.31; 18 biopsies in 6 studies) 8,76,84,126,128,138 , non-specific benign results (20.6%, 95% CI, 17.8–23.4%; I 2 = 0.96; 2574 biopsies in 64 studies) 4,6,8,11,12,19,22,23,26–28,…”

Section: Resultsmentioning

confidence: 99%

Non-diagnostic Results of Percutaneous Transthoracic Needle Biopsy: A Meta-analysis

Chae

Hong

Yoon

et al. 2019

Sci Rep

View full text Add to dashboard Cite

Non-diagnostic results can affect the diagnostic performance of percutaneous transthoracic needle biopsy (PTNB) but have not been critically meta-analyzed yet. To meta-analyze the incidence and malignancy rate of non-diagnostic results, 3-by-2 table approaches rather than the conventional 2-by-2 approaches are needed to know its impact on the diagnostic performance of PTNB. A systematic literature search identified studies evaluating the diagnostic performance of PTNB with extractable outcomes. A total of 143 studies with 35,059 biopsies were included. The pooled incidence of non-diagnostic results was 6.8% (95% CI, 6.0–7.6%; I 2 = 0.91). The pooled malignancy rate of non-diagnostic results was 59.3% (95% CI, 51.7–66.8%; I 2 = 0.80), and was correlated with the prevalence of malignancy (correlation coefficient, 0.66; 95% CI, 0.42–0.91). Pooled percentage decrease of sensitivity and specificity due to non-diagnostic results were 4.5% (95% CI, 3.2–5.7%; I 2 = 0.64) and 10.7% (95% CI, 7.7–13.7%; I 2 = 0.70), respectively, and the pooled incidence of non-diagnostic results was 4.4% (95% CI, 3.2–5.8%; I 2 = 0.83) in lesions ultimately diagnosed as malignancies and 10.4% (95% CI, 7.5–13.8%; I 2 = 0.74) in benign disease. In conclusion, non-diagnostic results averagely occurred in 6.8% of PTNB and more than half of the results were malignancies. The non-diagnostic results decreased specificity and sensitivity by 10.7% and 4.5%, respectively, demanding efforts to minimize the non-diagnostic results in PTNB.

show abstract

“…Several reports have demonstrated that clinical, radiological, and procedural factors are related to the risks of complications (18-20). Yeow et al (21) reported a higher rate of pneumothorax in lesions <2 cm and deeper than 0.1-2 cm and for procedures performed by less-experienced radiologists.…”

Section: Discussionmentioning

confidence: 99%

CT-guided biopsy of lung lesions: defining the best needle option for a specific diagnosis

Guimarães¹,

Marchiori²,

Hochhegger³

et al. 2014

Clinics

View full text Add to dashboard Cite

OBJECTIVES:To evaluate the performance of fine and cutting needles in computed tomography guided-biopsy of lung lesions suspicious for malignancy and to determine which technique is the best option for a specific diagnosis.METHODS:This retrospective study reviewed the data from 362 (71.6%) patients who underwent fine-needle aspiration biopsy and from 97 (19.7%) patients who underwent cutting-needle biopsy between January 2006 and December 2011. The data concerning demographic and lesion characteristics, procedures, biopsy sample adequacy, specific diagnoses, and complications were collected. The success and complication rates of both biopsy techniques were calculated.RESULTS:Cutting-needle biopsy yielded significantly higher percentages of adequate biopsy samples and specific diagnoses than did fine-needle aspiration biopsy (p<0.05). The sensitivity, specificity, and accuracy of cutting-needle biopsy were 93.8%, 97.3%, and 95.2%, respectively; those of fine-needle aspiration biopsy were 82.6%, 81.3%, and 81.8%, respectively (all p<0.05). The incidence of pneumothorax was higher for fine-needle aspiration biopsy, and that of hematoma was higher for cutting-needle biopsy (both p<0.05).CONCLUSIONS:Our experience using these two techniques for computed tomography-guided percutaneous biopsy showed that cutting-needle biopsy yielded better results than did fine-needle aspiration biopsy and that there was no significant increase in complication rates to indicate the best option for specific diagnoses.

show abstract

Biópsia aspirativa transtorácica por agulha fina guiada por TC de lesões pulmonares: resultados e complicações

Cited by 14 publications

References 19 publications

Lung cancer in Brazil

Lung cancer in Brazil

Non-diagnostic Results of Percutaneous Transthoracic Needle Biopsy: A Meta-analysis

CT-guided biopsy of lung lesions: defining the best needle option for a specific diagnosis

Contact Info

Product

Resources

About